Search

everythinglearnresearchcommunity

for

Search:↓

A child with a rare scalp condition regrew hair after treatment.

Some drugs used to treat immune conditions may cause different types of hair loss.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Hair loss is linked to heart disease and metabolic syndrome, and while current treatments vary in effectiveness, more research is needed for better solutions.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Hair loss in androgenic alopecia may be linked to increased local androgen activities, but not to estrogen levels.

Low dose cyclical nutrition therapy can consistently and safely improve hair growth and density without needing anti-androgens.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Myasthenia gravis can affect both motor and non-motor systems due to immune system issues.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

Honokiol from Magnolia plants may be beneficial for treating various skin conditions and promoting hair growth.

Gynostemma pentaphyllum and its component damulin B could help hair grow by activating certain cell pathways.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

Ketoconazole lotion can improve hair regrowth for some people with androgenetic alopecia.

Rice husk and bran extracts from the Bue Bang 3 CMU variety can potentially treat hair loss due to their antioxidant, anti-inflammatory, and anti-androgenic properties.

Autoimmune myopathy may be linked to hair loss and skin depigmentation.

C3G and Vitisin A may help prevent hair loss by blocking male hormones and stopping hair cell death.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.